Ucsf Pulmonary Disease is categorized under Medical Centers in San Francisco, CA .
Ucsf Pulmonary Disease was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mary Kleinhenz, Office Manager at the company’s single location by writing to 400 Parnassus Avenue # 5, San Francisco, California CA 94143 or by phoning (415) 353-2961. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ucsf Pulmonary Disease |
Contact Person: | Mary Kleinhenz, Office Manager |
Address: | 400 Parnassus Avenue # 5, San Francisco, California 94143 |
Phone Number: | (415) 353-2961 |
Website Address: | radiology.ucsf.edu |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Centers |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Ucsf Pulmonary Disease was started in 0 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Mary Kleinhenz, Office Manager for inquiries that concern Ucsf Pulmonary Disease by calling the company number (415) 353-2961, as your correspondence is most welcome. Additionally, the physical location of the single location of Ucsf Pulmonary Disease can be found at the coordinates 37.76324,-122.45866 as well as the street address 400 Parnassus Avenue # 5 in San Francisco, California 94143.
For its online presence, you may visit Ucsf Pulmonary Disease’s website at radiology.ucsf.edu and engage with its social media outlets through on Twitter and on Facebook.